Oorsprong van het eerstegraads netwerk van Frank W. Falkenberg
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frank W. Falkenberg via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Maastricht University | College/University | Corporate Officer/Principal | |
| Radboud University Nijmegen | College/University | Doctorate Degree | |
| NovoVacs BV | Founder | ||
AdjuTec BV
 AdjuTec BV Pharmaceuticals: MajorHealth Technology AdjuTec BV is a Dutch company that manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients. The company is based in Maastricht, Netherlands. The company was founded in 2017 by René Vleugels. | Pharmaceuticals: Major | Founder |
Statistieken
Internationaal
| Nederland | 6 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Operationeel
| Founder | 4 |
| President | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| René Vleugels | 6 |
- Beurs
- Insiders
- Frank W. Falkenberg
- Bedrijfsconnecties
